TOP STORIES

• BUSINESS Japanese Pricing Rules Don’t Fully Capture Value of New Modalities, “No” to CEA Expansion: Janssen Exec
  November 17, 2023

• REGULATORY Wegovy Lands Reimbursement Listing in Japan 8 Months after Approval
  November 16, 2023

• ORGANIZATION PhRMA Chief Presses Japan to Cut LLP Spending, Shift Funds towards Innovation
  November 15, 2023

• REGULATORY Japan Health Minister Seeks Industry Input for Detailed Discussions on Innovation Ecosystem
  November 14, 2023

• BUSINESS Ajinomoto to Acquire US Gene Therapy CDMO for US$554 Million
  November 14, 2023

• REGULATORY MHLW Proposes New Premium with Easier-than-Sakigake Requirements to Fight Lag, Loss
  November 13, 2023

• REGULATORY Japan Panel Supports Certain Out-of-Pocket Payment for LLP-Generic Price Gap
  November 10, 2023

• ORGANIZATION PhRMA Chair Urges Japan to Maintain On-Patent Drug Prices, Improve Initial Pricing
  November 10, 2023

• BUSINESS Middle East Unrest Threatens Supply of Kaken’s Burn Eschar Remover
  November 9, 2023

• REGULATORY Health Minister Asks 24 Makers to Raise Production of Antitussives, Expectorants; Firms Want Regulatory, Pricing Steps
  November 8, 2023

• REGULATORY Govt to Support Shift to 24-Hour Production for Cough Drugs: Minister
  November 8, 2023

• BUSINESS Eisai CEO Confident of Achieving Leqembi Sales Goal of 10 Billion Yen in FY2023
  November 8, 2023

• BUSINESS Air Pollutant Might Be to Blame for NDMA Formation in Metformin: Towa Paper
  November 7, 2023

• BUSINESS Chugai Offloading Xeloda to Cheplapharm after German Firm Plants Flag in Japan
  November 7, 2023

• REGULATORY Health Minister to Make Direct Request to 24 Makers for Supply Ramp-Up
  November 7, 2023

• REGULATORY Japan PM Advisor Pushes Rethink of LLP Coverage to Reward Innovation, Pricing Debate without Taboos
  November 6, 2023

• REGULATORY Japan OKs New Economic Package; Startup, Pharma Promotion Embraced
  November 6, 2023

• REGULATORY Reward Innovation by Revisiting LLP Copay, Cut Doctor Fees: MOF
  November 2, 2023

• BUSINESS Sumitomo Eyes Return to Core Operating Profit in FY2024, Pruning Roivant Shares
  November 1, 2023

• BUSINESS 301 Employees Apply for Shionogi’s Voluntary Buyout Program
  November 1, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 39
• 40
• 41
• 42
• 43
• 44
• 45
• 46
• 47
• …
• Next ›
• 最終 »